| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | focal adhesion assembly | 1.55e-08 | 97 | 95 | 8 | GO:0048041 | |
| GeneOntologyBiologicalProcess | cell-substrate junction assembly | 3.62e-08 | 108 | 95 | 8 | GO:0007044 | |
| GeneOntologyBiologicalProcess | cell-substrate junction organization | 5.93e-08 | 115 | 95 | 8 | GO:0150115 | |
| GeneOntologyBiologicalProcess | regulation of focal adhesion assembly | 8.41e-07 | 70 | 95 | 6 | GO:0051893 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate junction assembly | 8.41e-07 | 70 | 95 | 6 | GO:0090109 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate junction organization | 1.27e-06 | 75 | 95 | 6 | GO:0150116 | |
| GeneOntologyBiologicalProcess | regulation of cell-matrix adhesion | 4.02e-06 | 141 | 95 | 7 | GO:0001952 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 4.35e-06 | 270 | 95 | 9 | GO:0007160 | |
| GeneOntologyBiologicalProcess | cell junction assembly | GPM6B SLK CLASP1 MYO9A ITGA2 THSD1 CDH20 TLN1 GPC4 MACF1 TLN2 SMAD3 | 1.18e-05 | 569 | 95 | 12 | GO:0034329 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 1.94e-05 | 410 | 95 | 10 | GO:0031589 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate adhesion | 2.29e-05 | 254 | 95 | 8 | GO:0010810 | |
| GeneOntologyBiologicalProcess | nuclear division | KNTC1 WAPL CLASP1 MCMDC2 NSMCE2 SGO1 CDC14B RAD51AP1 SGO2 SKA1 MYBL2 | 2.36e-05 | 512 | 95 | 11 | GO:0000280 |
| GeneOntologyBiologicalProcess | organelle fission | KNTC1 WAPL CLASP1 MCMDC2 NSMCE2 SGO1 CDC14B RAD51AP1 SGO2 SKA1 MYBL2 | 6.34e-05 | 571 | 95 | 11 | GO:0048285 |
| GeneOntologyBiologicalProcess | cell cycle process | KNTC1 WAPL CLASP1 UBD ECD MCMDC2 NSMCE2 SGO1 CDC14B BLM RAD51AP1 TTI1 SGO2 GPNMB CKAP2 SKA1 USP47 MYBL2 | 8.98e-05 | 1441 | 95 | 18 | GO:0022402 |
| GeneOntologyBiologicalProcess | regulation of sister chromatid cohesion | 1.02e-04 | 20 | 95 | 3 | GO:0007063 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | KNTC1 WAPL CLASP1 UBD ECD NSMCE2 CDC14B BLM GPNMB CKAP2 SKA1 USP47 MYBL2 | 1.45e-04 | 854 | 95 | 13 | GO:1903047 |
| GeneOntologyBiologicalProcess | mitotic cell cycle | KNTC1 WAPL CLASP1 UBD ECD PTCH1 NSMCE2 CDC14B BLM GPNMB CKAP2 SKA1 USP47 MYBL2 | 2.18e-04 | 1014 | 95 | 14 | GO:0000278 |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | 2.40e-04 | 356 | 95 | 8 | GO:0098813 | |
| GeneOntologyBiologicalProcess | sister chromatid cohesion | 2.59e-04 | 67 | 95 | 4 | GO:0007062 | |
| GeneOntologyBiologicalProcess | chromosome segregation | 2.95e-04 | 465 | 95 | 9 | GO:0007059 | |
| GeneOntologyBiologicalProcess | chromosome organization | KNTC1 WAPL CLASP1 MCMDC2 NSMCE2 SGO1 MAP3K4 BLM SGO2 SKA1 MYBL2 | 3.14e-04 | 686 | 95 | 11 | GO:0051276 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | GPM6B SLK CLASP1 ITGA2 BLM LPA TLN1 MACF1 GPNMB UTRN PLXNA2 KNG1 SMAD3 | 3.22e-04 | 927 | 95 | 13 | GO:0030155 |
| GeneOntologyBiologicalProcess | cell division | KNTC1 WAPL CLASP1 PTCH1 NSMCE2 SGO1 CDC14B BLM SGO2 CKAP2 SKA1 | 3.60e-04 | 697 | 95 | 11 | GO:0051301 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | KNTC1 GPM6B USP30 SYNPO2 WAPL CLASP1 NSMCE2 MAP3K4 RAD51AP1 MYO3A CYRIA SGO2 SSH2 CKAP2 SKA1 SMAD3 | 3.93e-04 | 1342 | 95 | 16 | GO:0033043 |
| GeneOntologyBiologicalProcess | positive regulation of maintenance of sister chromatid cohesion | 4.34e-04 | 7 | 95 | 2 | GO:0034093 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid segregation | 4.46e-04 | 212 | 95 | 6 | GO:0000070 | |
| GeneOntologyBiologicalProcess | protein localization to cell surface | 4.87e-04 | 79 | 95 | 4 | GO:0034394 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | KNTC1 WAPL UBD ECD NSMCE2 CDC14B BLM RAD51AP1 TTI1 SGO2 GPNMB USP47 | 4.97e-04 | 845 | 95 | 12 | GO:0010564 |
| GeneOntologyBiologicalProcess | cell junction organization | GPM6B SLK CLASP1 MYO9A ITGA2 THSD1 SEZ6L2 CDH20 TLN1 GPC4 MACF1 TLN2 SMAD3 | 5.15e-04 | 974 | 95 | 13 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle phase transition | 5.39e-04 | 402 | 95 | 8 | GO:1901990 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle phase transition | 5.67e-04 | 509 | 95 | 9 | GO:0044772 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 5.67e-04 | 309 | 95 | 7 | GO:1901888 | |
| GeneOntologyBiologicalProcess | cell cycle phase transition | 6.22e-04 | 627 | 95 | 10 | GO:0044770 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | 6.25e-04 | 516 | 95 | 9 | GO:1901987 | |
| GeneOntologyBiologicalProcess | mitotic nuclear division | 6.48e-04 | 316 | 95 | 7 | GO:0140014 | |
| GeneOntologyBiologicalProcess | exit from mitosis | 6.57e-04 | 37 | 95 | 3 | GO:0010458 | |
| GeneOntologyBiologicalProcess | regulation of maintenance of sister chromatid cohesion | 9.22e-04 | 10 | 95 | 2 | GO:0034091 | |
| GeneOntologyCellularComponent | chromosomal region | 1.28e-04 | 421 | 95 | 9 | GO:0098687 | |
| GeneOntologyCellularComponent | mitotic spindle | 3.13e-04 | 201 | 95 | 6 | GO:0072686 | |
| GeneOntologyCellularComponent | condensed chromosome | 5.04e-04 | 307 | 95 | 7 | GO:0000793 | |
| GeneOntologyCellularComponent | microtubule | 7.16e-04 | 533 | 95 | 9 | GO:0005874 | |
| GeneOntologyCellularComponent | focal adhesion | 7.78e-04 | 431 | 95 | 8 | GO:0005925 | |
| GeneOntologyCellularComponent | cell-substrate junction | 9.29e-04 | 443 | 95 | 8 | GO:0030055 | |
| Domain | - | 2.51e-05 | 2 | 94 | 2 | 1.20.1420.10 | |
| Domain | CKAP2_C | 2.51e-05 | 2 | 94 | 2 | IPR029197 | |
| Domain | Talin_middle | 2.51e-05 | 2 | 94 | 2 | PF09141 | |
| Domain | VBS | 2.51e-05 | 2 | 94 | 2 | PF08913 | |
| Domain | CKAP2_fam | 2.51e-05 | 2 | 94 | 2 | IPR026165 | |
| Domain | Vinculin-bd_dom | 2.51e-05 | 2 | 94 | 2 | IPR015009 | |
| Domain | CKAP2_C | 2.51e-05 | 2 | 94 | 2 | PF15297 | |
| Domain | Talin_cent | 2.51e-05 | 2 | 94 | 2 | IPR015224 | |
| Domain | Ubiquitin-rel_dom | 4.00e-05 | 184 | 94 | 7 | IPR029071 | |
| Domain | Talin-1 | 7.49e-05 | 3 | 94 | 2 | IPR015710 | |
| Domain | Kinesin_light_repeat | 7.49e-05 | 3 | 94 | 2 | IPR015792 | |
| Domain | KINESIN_LIGHT | 7.49e-05 | 3 | 94 | 2 | PS01160 | |
| Domain | I_LWEQ | 1.49e-04 | 4 | 94 | 2 | PF01608 | |
| Domain | ILWEQ_dom | 1.49e-04 | 4 | 94 | 2 | IPR002558 | |
| Domain | I_LWEQ | 1.49e-04 | 4 | 94 | 2 | PS50945 | |
| Domain | ILWEQ | 1.49e-04 | 4 | 94 | 2 | SM00307 | |
| Domain | FERM_f0 | 1.49e-04 | 4 | 94 | 2 | IPR032425 | |
| Domain | FERM_f0 | 1.49e-04 | 4 | 94 | 2 | PF16511 | |
| Domain | ILWEQ | 1.49e-04 | 4 | 94 | 2 | PD011820 | |
| Domain | Kinesin_light | 1.49e-04 | 4 | 94 | 2 | IPR002151 | |
| Domain | - | 1.49e-04 | 4 | 94 | 2 | 1.20.1410.10 | |
| Domain | Rab5-bind | 3.71e-04 | 6 | 94 | 2 | PF09311 | |
| Domain | Rabaptin_Rab5-bd_dom | 3.71e-04 | 6 | 94 | 2 | IPR015390 | |
| Domain | TPR_10 | 3.71e-04 | 6 | 94 | 2 | PF13374 | |
| Domain | Vinculin/catenin | 5.18e-04 | 7 | 94 | 2 | IPR006077 | |
| Domain | IRS_PTB | 2.19e-03 | 14 | 94 | 2 | IPR002404 | |
| Domain | IRS | 2.19e-03 | 14 | 94 | 2 | PF02174 | |
| Domain | ARM-like | 2.43e-03 | 270 | 94 | 6 | IPR011989 | |
| Domain | IQ | 5.51e-03 | 71 | 94 | 3 | PF00612 | |
| Domain | Actinin_actin-bd_CS | 5.92e-03 | 23 | 94 | 2 | IPR001589 | |
| Domain | Spectrin | 5.92e-03 | 23 | 94 | 2 | PF00435 | |
| Domain | ACTININ_2 | 5.92e-03 | 23 | 94 | 2 | PS00020 | |
| Domain | ACTININ_1 | 5.92e-03 | 23 | 94 | 2 | PS00019 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 2.77e-05 | 127 | 66 | 6 | M27181 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 3.03e-05 | 129 | 66 | 6 | MM14894 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 1.03e-04 | 100 | 66 | 5 | MM14561 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 1.69e-04 | 111 | 66 | 5 | M27673 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 1.92e-04 | 257 | 66 | 7 | MM14755 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 2.16e-04 | 117 | 66 | 5 | MM15387 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 2.65e-04 | 191 | 66 | 6 | M29614 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 2.80e-04 | 193 | 66 | 6 | MM14890 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 3.57e-04 | 202 | 66 | 6 | MM15362 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 3.64e-04 | 30 | 66 | 3 | M47724 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 3.77e-04 | 204 | 66 | 6 | M4217 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 4.94e-04 | 140 | 66 | 5 | M27550 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 5.11e-04 | 141 | 66 | 5 | MM15266 | |
| Pathway | WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME | 5.29e-04 | 34 | 66 | 3 | M42555 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 7.59e-04 | 323 | 66 | 7 | M27080 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 7.61e-04 | 9 | 66 | 2 | MM15030 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_ANTEROGRADE_AXONAL_TRANSPORT | 7.61e-04 | 9 | 66 | 2 | M47699 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAB_C_D_TO_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 7.61e-04 | 9 | 66 | 2 | M47725 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 7.76e-04 | 234 | 66 | 6 | MM14898 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 8.12e-04 | 236 | 66 | 6 | M27185 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 8.17e-04 | 649 | 66 | 10 | MM15690 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_KTN1 | 1.16e-03 | 11 | 66 | 2 | M27490 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_KTN1 | 1.16e-03 | 11 | 66 | 2 | MM15218 | |
| Pubmed | 3.13e-07 | 322 | 97 | 9 | 26514267 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | KNTC1 WAPL CLASP1 ECD NSMCE2 SGO1 BLM PLAA TLN1 SGO2 TLN2 ZMYM4 USP47 SMAD3 MYBL2 | 7.30e-07 | 1155 | 97 | 15 | 20360068 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CLASP1 MYO9A COBLL1 KLC4 NSMCE2 IFRD1 TET1 RNF10 MACF1 SSH2 CKAP2 UTRN KLC1 | 8.23e-07 | 861 | 97 | 13 | 36931259 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | WAPL SGO1 TRIM24 JMJD1C BLM RAD51AP1 SGO2 ZMYM4 GABPA ZNF292 MYBL2 | 1.09e-06 | 608 | 97 | 11 | 36089195 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | WAPL CLASP1 IQCN ECPAS BLM MYO3A CCNYL1 TLN2 ZMYM4 USP47 ZNF687 MYBL2 | 1.72e-06 | 774 | 97 | 12 | 15302935 |
| Pubmed | SLK DDX59 ECD SGO1 RAD51AP1 TLN1 SGO2 CKAP2 SKA1 UTRN ZNF687 | 1.93e-06 | 645 | 97 | 11 | 25281560 | |
| Pubmed | HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP. | 2.47e-06 | 34 | 97 | 4 | 25925205 | |
| Pubmed | 2.70e-06 | 418 | 97 | 9 | 34709266 | ||
| Pubmed | 3.72e-06 | 83 | 97 | 5 | 9039502 | ||
| Pubmed | 4.69e-06 | 87 | 97 | 5 | 33798452 | ||
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 5.41e-06 | 157 | 97 | 6 | 30686591 | |
| Pubmed | 7.20e-06 | 472 | 97 | 9 | 38943005 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 26822056 | ||
| Pubmed | Extracellular rigidity sensing by talin isoform-specific mechanical linkages. | 7.70e-06 | 2 | 97 | 2 | 26523364 | |
| Pubmed | Loss of Blm enhances basal cell carcinoma and rhabdomyosarcoma tumorigenesis in Ptch1+/- mice. | 7.70e-06 | 2 | 97 | 2 | 19995795 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 27895300 | ||
| Pubmed | The conserved kinetochore protein shugoshin protects centromeric cohesion during meiosis. | 7.70e-06 | 2 | 97 | 2 | 14730319 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 36778114 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 22306379 | ||
| Pubmed | Chimeric RNA ASTN2-PAPPAas aggravates tumor progression and metastasis in human esophageal cancer. | 7.70e-06 | 2 | 97 | 2 | 33388371 | |
| Pubmed | 1.19e-05 | 503 | 97 | 9 | 16964243 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ABR MYO9A TM9SF4 IQCN ECPAS NSMCE2 CDC14B JMJD1C IFRD1 MACF1 ASTN2 RPRD2 CKAP2 UTRN ZMYM4 | 1.58e-05 | 1489 | 97 | 15 | 28611215 |
| Pubmed | 1.91e-05 | 116 | 97 | 5 | 30804394 | ||
| Pubmed | 2.00e-05 | 57 | 97 | 4 | 29089450 | ||
| Pubmed | Type I gamma phosphatidylinositol phosphate kinase targets and regulates focal adhesions. | 2.31e-05 | 3 | 97 | 2 | 12422220 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 33827130 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 31924815 | ||
| Pubmed | Mechanotransduction in talin through the interaction of the R8 domain with DLC1. | 2.31e-05 | 3 | 97 | 2 | 30028837 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 19952892 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 19160486 | ||
| Pubmed | Talin and vinculin are downregulated in atherosclerotic plaque; Tampere Vascular Study. | 2.31e-05 | 3 | 97 | 2 | 27816808 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 28781233 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 25939412 | ||
| Pubmed | Cytoskeletal proteins talin and vinculin in integrin-mediated adhesion. | 2.31e-05 | 3 | 97 | 2 | 15494027 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 18792400 | ||
| Pubmed | Vinculin controls talin engagement with the actomyosin machinery. | 2.31e-05 | 3 | 97 | 2 | 26634421 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 22665520 | ||
| Pubmed | An essential role for talin during alpha(M)beta(2)-mediated phagocytosis. | 2.31e-05 | 3 | 97 | 2 | 17202407 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 28698364 | ||
| Pubmed | Characterization of the zinc finger proteins ZMYM2 and ZMYM4 as novel B-MYB binding proteins. | 2.31e-05 | 3 | 97 | 2 | 32439918 | |
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 2.74e-05 | 125 | 97 | 5 | 32891193 | |
| Pubmed | 2.75e-05 | 209 | 97 | 6 | 36779422 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | WAPL ECPAS TRIM24 JMJD1C BLM IFRD1 ZMYM4 GABPA USP47 SMAD3 MYBL2 | 2.76e-05 | 857 | 97 | 11 | 25609649 |
| Pubmed | 3.30e-05 | 216 | 97 | 6 | 31519766 | ||
| Pubmed | 3.85e-05 | 222 | 97 | 6 | 37071664 | ||
| Pubmed | 4.15e-05 | 225 | 97 | 6 | 12168954 | ||
| Pubmed | 4.42e-05 | 335 | 97 | 7 | 15741177 | ||
| Pubmed | A mouse knockout library for secreted and transmembrane proteins. | 4.56e-05 | 460 | 97 | 8 | 20562862 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 31019073 | ||
| Pubmed | Structure of cohesin subcomplex pinpoints direct shugoshin-Wapl antagonism in centromeric cohesion. | 4.60e-05 | 4 | 97 | 2 | 25173175 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 30242097 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 34392614 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 30372567 | ||
| Pubmed | Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). | 4.60e-05 | 4 | 97 | 2 | 9989976 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 21134644 | ||
| Pubmed | Vinculin regulates assembly of talin: β3 integrin complexes. | 4.60e-05 | 4 | 97 | 2 | 24446374 | |
| Pubmed | Endothelial cell talin1 is essential for embryonic angiogenesis. | 4.60e-05 | 4 | 97 | 2 | 21081121 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 15581353 | ||
| Pubmed | 4.76e-05 | 339 | 97 | 7 | 30415952 | ||
| Pubmed | KNTC1 CLASP1 ECPAS TRIM24 JMJD1C TLN1 TARS1 ZMYM4 GABPA ZNF687 ZNF292 MYBL2 | 5.83e-05 | 1103 | 97 | 12 | 34189442 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 6.00e-05 | 934 | 97 | 11 | 33916271 | |
| Pubmed | 6.94e-05 | 360 | 97 | 7 | 33111431 | ||
| Pubmed | Role of CLASP2 in microtubule stabilization and the regulation of persistent motility. | 7.66e-05 | 5 | 97 | 2 | 17113391 | |
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 19805288 | ||
| Pubmed | Talin1 regulates integrin turnover to promote embryonic epithelial morphogenesis. | 7.66e-05 | 5 | 97 | 2 | 21670148 | |
| Pubmed | Quantification of integrin receptor agonism by fluorescence lifetime imaging. | 7.66e-05 | 5 | 97 | 2 | 18216331 | |
| Pubmed | Unified mode of centromeric protection by shugoshin in mammalian oocytes and somatic cells. | 7.66e-05 | 5 | 97 | 2 | 18084284 | |
| Pubmed | Talin is required for integrin-mediated platelet function in hemostasis and thrombosis. | 7.66e-05 | 5 | 97 | 2 | 18086863 | |
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 2081600 | ||
| Pubmed | Detailed physical and genetic mapping in the region of plasminogen, D17Rp17e, and quaking. | 7.66e-05 | 5 | 97 | 2 | 8111116 | |
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 26821125 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 7.81e-05 | 497 | 97 | 8 | 36774506 | |
| Pubmed | 9.40e-05 | 162 | 97 | 5 | 15174051 | ||
| Pubmed | 1.06e-04 | 87 | 97 | 4 | 12465718 | ||
| Pubmed | Mice carrying a complete deletion of the talin2 coding sequence are viable and fertile. | 1.15e-04 | 6 | 97 | 2 | 22925892 | |
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 21666598 | ||
| Pubmed | 1.48e-04 | 407 | 97 | 7 | 12693553 | ||
| Pubmed | 1.55e-04 | 549 | 97 | 8 | 38280479 | ||
| Pubmed | Talin regulates integrin β1-dependent and -independent cell functions in ureteric bud development. | 1.60e-04 | 7 | 97 | 2 | 28993400 | |
| Pubmed | Familial STAG2 germline mutation defines a new human cohesinopathy. | 1.60e-04 | 7 | 97 | 2 | 29263825 | |
| Pubmed | 1.60e-04 | 7 | 97 | 2 | 12874272 | ||
| Pubmed | Phosphorylation of the CPC by Cdk1 promotes chromosome bi-orientation. | 1.60e-04 | 7 | 97 | 2 | 20739936 | |
| Pubmed | SHARPIN is an endogenous inhibitor of β1-integrin activation. | 1.60e-04 | 7 | 97 | 2 | 21947080 | |
| Pubmed | 1.60e-04 | 7 | 97 | 2 | 23266827 | ||
| Pubmed | 1.66e-04 | 708 | 97 | 9 | 39231216 | ||
| Pubmed | 1.67e-04 | 415 | 97 | 7 | 16385451 | ||
| Pubmed | GPM6B SLK CLASP1 MYO9A ITGA2 TLN1 MACF1 TLN2 SSH2 UTRN TARS1 KNG1 KLC1 | 1.72e-04 | 1431 | 97 | 13 | 37142655 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | THEMIS2 USP30 MYO9A TM9SF4 SGO1 JMJD1C COG6 TET1 RNF10 SGO2 PLXNA2 KNG1 | 1.77e-04 | 1242 | 97 | 12 | 30973865 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | KNTC1 SLK ECPAS KLC4 PTPN12 PLAA TLN1 TTI1 MACF1 TARS1 GABPA KLC1 USP47 | 2.02e-04 | 1455 | 97 | 13 | 22863883 |
| Pubmed | 2.13e-04 | 8 | 97 | 2 | 11381084 | ||
| Pubmed | A genome-wide association study of total serum and mite-specific IgEs in asthma patients. | 2.13e-04 | 8 | 97 | 2 | 23967269 | |
| Pubmed | 2.13e-04 | 8 | 97 | 2 | 1845916 | ||
| Pubmed | NSMCE2 suppresses cancer and aging in mice independently of its SUMO ligase activity. | 2.13e-04 | 8 | 97 | 2 | 26443207 | |
| Pubmed | 2.13e-04 | 8 | 97 | 2 | 22017400 | ||
| Pubmed | Arginylation-dependent neural crest cell migration is essential for mouse development. | 2.13e-04 | 8 | 97 | 2 | 20300656 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 2.31e-04 | 910 | 97 | 10 | 36736316 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 2.39e-04 | 440 | 97 | 7 | 34244565 | |
| Pubmed | WAPL CYRIA RNF10 MACF1 ASTN2 TLN2 CKAP2 UTRN TARS1 ZMYM4 USP47 ZNF292 | 2.42e-04 | 1285 | 97 | 12 | 35914814 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 2.46e-04 | 588 | 97 | 8 | 38580884 | |
| Pubmed | 2.74e-04 | 9 | 97 | 2 | 22976293 | ||
| Interaction | GYPA interactions | 1.69e-06 | 174 | 95 | 8 | int:GYPA | |
| Interaction | MTNR1B interactions | 3.50e-06 | 135 | 95 | 7 | int:MTNR1B | |
| Interaction | H2BC8 interactions | DDX59 WAPL SGO1 TRIM24 BLM RAD51AP1 SGO2 CKAP2 ZMYM4 ZNF687 ZNF292 MYBL2 | 1.67e-05 | 576 | 95 | 12 | int:H2BC8 |
| Interaction | RGCC interactions | 2.16e-05 | 12 | 95 | 3 | int:RGCC | |
| Cytoband | 9q22.3 | 2.88e-04 | 12 | 97 | 2 | 9q22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q26 | 5.20e-04 | 16 | 97 | 2 | chr6q26 | |
| Cytoband | 6q26 | 6.61e-04 | 18 | 97 | 2 | 6q26 | |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN | 3.14e-08 | 190 | 95 | 9 | M761 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP | 6.88e-07 | 200 | 95 | 8 | M3577 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_2_CELL | 1.48e-06 | 300 | 95 | 9 | M45675 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_UP | 8.22e-06 | 199 | 95 | 7 | M8961 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 8.49e-06 | 200 | 95 | 7 | M3580 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SLK WAPL CLASP1 TRIM24 MAP3K4 BLM IFRD1 PTPN12 MACF1 ZMYM4 KLC1 SMAD3 ZNF292 | 1.29e-05 | 856 | 95 | 13 | M4500 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGBP | 1.38e-05 | 300 | 95 | 8 | M39059 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL | 2.29e-05 | 322 | 95 | 8 | M39060 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | KNTC1 WAPL NSMCE2 SGO1 TRIM24 BLM RAD51AP1 PLAA NXT1 CKAP2L TTI1 SGO2 CKAP2 SKA1 TARS1 MYBL2 | 2.96e-05 | 1363 | 95 | 16 | M45782 |
| Coexpression | GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 3.56e-05 | 169 | 95 | 6 | M9102 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL | KNTC1 SGO1 BLM RAD51AP1 CCNYL1 CKAP2L SGO2 IL17RD SKA1 MYBL2 | 4.03e-05 | 567 | 95 | 10 | M45692 |
| Coexpression | VILLANUEVA_LIVER_CANCER_KRT19_UP | 4.32e-05 | 175 | 95 | 6 | M336 | |
| Coexpression | FISCHER_DREAM_TARGETS | KNTC1 SGO1 BLM RAD51AP1 IFRD1 NXT1 CKAP2L TTI1 SGO2 CKAP2 SKA1 TARS1 MYBL2 | 4.70e-05 | 969 | 95 | 13 | M149 |
| Coexpression | GSE14415_NATURAL_TREG_VS_TCONV_DN | 5.06e-05 | 180 | 95 | 6 | M2961 | |
| Coexpression | GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP | 5.06e-05 | 180 | 95 | 6 | M2941 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | ABR COBLL1 ITGA2 KLC4 JMJD1C RASSF5 IFRD1 NXT1 TLN1 GPNMB PLXNA2 SMAD3 | 5.36e-05 | 843 | 95 | 12 | M2356 |
| Coexpression | MEBARKI_HCC_PROGENITOR_FZD8CRD_UP | 5.47e-05 | 588 | 95 | 10 | M38992 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | 6.07e-05 | 478 | 95 | 9 | M45785 | |
| Coexpression | GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_UP | 9.05e-05 | 200 | 95 | 6 | M5838 | |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_DN | 9.05e-05 | 200 | 95 | 6 | M8257 | |
| Coexpression | GSE18893_TCONV_VS_TREG_24H_TNF_STIM_UP | 9.05e-05 | 200 | 95 | 6 | M7308 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_DN | 9.05e-05 | 200 | 95 | 6 | M8486 | |
| Coexpression | GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN | 9.05e-05 | 200 | 95 | 6 | M7150 | |
| Coexpression | GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_DN | 9.05e-05 | 200 | 95 | 6 | M9277 | |
| Coexpression | GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_UP | 9.05e-05 | 200 | 95 | 6 | M5623 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL | 9.09e-05 | 290 | 95 | 7 | M45736 | |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | 1.78e-04 | 432 | 95 | 8 | MM419 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_SCHWANN_PRECURSOR_CELL | 2.03e-04 | 232 | 95 | 6 | M45800 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | 2.12e-04 | 694 | 95 | 10 | M45767 | |
| Coexpression | CHICAS_RB1_TARGETS_CONFLUENT | 2.20e-04 | 567 | 95 | 9 | M2129 | |
| Coexpression | ZHONG_PFC_C1_OPC | 2.33e-04 | 238 | 95 | 6 | M39096 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST | 2.34e-04 | 450 | 95 | 8 | M45747 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 2.44e-04 | 240 | 95 | 6 | M39236 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | 2.53e-04 | 578 | 95 | 9 | M2368 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 2.56e-04 | 155 | 95 | 5 | M39041 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | 2.66e-04 | 714 | 95 | 10 | M1744 | |
| Coexpression | GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_DN | 2.80e-04 | 158 | 95 | 5 | M8595 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | THEMIS2 VGLL3 CLASP1 MYO9A CYRIA PTPN12 NXT1 TTI1 ASTN2 SSH2 IL17RD PLXNA2 | 2.87e-04 | 1009 | 95 | 12 | M157 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 2.96e-04 | 466 | 95 | 8 | M13522 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | 3.21e-04 | 597 | 95 | 9 | MM1309 | |
| Coexpression | BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 | 3.55e-04 | 92 | 95 | 4 | M11682 | |
| Coexpression | ZHONG_PFC_C3_UNKNOWN_INP | 3.55e-04 | 38 | 95 | 3 | M39083 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 3.59e-04 | 363 | 95 | 7 | M41103 | |
| Coexpression | GSE7219_WT_VS_NIK_NFKB2_KO_DC_DN | 3.81e-04 | 169 | 95 | 5 | M379 | |
| Coexpression | GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 4.02e-04 | 171 | 95 | 5 | M9092 | |
| Coexpression | DESCARTES_ORGANOGENESIS_PREMATURE_OLIGODENDROCYTE | 4.13e-04 | 40 | 95 | 3 | MM3636 | |
| Coexpression | KIM_MYC_AMPLIFICATION_TARGETS_DN | 4.51e-04 | 98 | 95 | 4 | M6319 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 4.59e-04 | 176 | 95 | 5 | M2981 | |
| Coexpression | GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 4.59e-04 | 176 | 95 | 5 | M9137 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | 4.60e-04 | 498 | 95 | 8 | M1741 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | WAPL THSD7A ECPAS SGO1 TRIM24 RAD51AP1 MYO3A CCNYL1 TET1 TTI1 SGO2 SKA1 ZNF292 | 1.49e-07 | 469 | 94 | 13 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | SLK NWD1 AFF2 ECPAS TRIM24 CDC14B TET1 CKAP2L TTI1 MACF1 SKA1 ZNF292 | 4.57e-07 | 432 | 94 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | GPM6B DDX59 WAPL AFF2 CLASP1 SGO1 TRIM24 BLM RAD51AP1 PTPN12 PCDH19 TET1 CKAP2L TTI1 MACF1 SGO2 PAPPA SKA1 ZNF292 MYBL2 | 4.82e-06 | 1459 | 94 | 20 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | KNTC1 COBLL1 SGO1 CDC14B BLM RAD51AP1 CKAP2L SGO2 CKAP2 MYBL2 | 1.38e-05 | 410 | 94 | 10 | GSM538387_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | VGLL3 THSD7A SGO1 GGT5 RAD51AP1 PCDH19 TET1 CKAP2L SGO2 PAPPA RPRD2 SLC2A13 SKA1 KNG1 | 1.43e-05 | 819 | 94 | 14 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | GPM6B DDX59 WAPL THSD7A CLASP1 PTCH1 SGO1 TRIM24 BLM RAD51AP1 CKAP2L MACF1 SGO2 PAPPA ZNF292 MYBL2 | 1.55e-05 | 1060 | 94 | 16 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.58e-05 | 71 | 94 | 5 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000 | GPM6B SYNPO2 VGLL3 ABR TM9SF4 THSD1 RAD51AP1 CYRIA CKAP2L SGO2 CKAP2 TARS1 PLXNA2 ZNF292 | 1.83e-05 | 837 | 94 | 14 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | WAPL ECPAS SGO1 MAP3K4 RAD51AP1 IFRD1 PTPN12 PLAA SGO2 PAPPA SKA1 | 2.33e-05 | 532 | 94 | 11 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | DDX59 WAPL CLASP1 SGO1 TRIM24 BLM RAD51AP1 PTPN12 TET1 CKAP2L TTI1 MACF1 SGO2 PAPPA SKA1 ZNF292 MYBL2 | 3.32e-05 | 1257 | 94 | 17 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | 6.68e-05 | 397 | 94 | 9 | GSM791143_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.67e-05 | 51 | 94 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k1 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3 | 1.01e-04 | 419 | 94 | 9 | GSM476664_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500 | 1.04e-04 | 421 | 94 | 9 | gudmap_developingKidney_e15.5_Peripheral blastema_500 | |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | 1.06e-04 | 422 | 94 | 9 | GSM538355_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | GPM6B DDX59 WAPL THSD7A AFF2 CLASP1 PTCH1 SGO1 TRIM24 BLM RAD51AP1 CKAP2L MACF1 SGO2 PAPPA ZNF292 MYBL2 | 1.42e-04 | 1414 | 94 | 17 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | GPM6B VGLL3 AFF2 PTCH1 SGO1 CYRIA TET1 CKAP2L SGO2 CKAP2 SMAD3 ARMH4 | 1.61e-04 | 777 | 94 | 12 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.97e-04 | 564 | 94 | 10 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.13e-04 | 291 | 94 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500 | 3.75e-04 | 396 | 94 | 8 | gudmap_dev gonad_e13.5_M_GermCell_Oct_500 | |
| CoexpressionAtlas | alpha beta T cells, NKT.44-NK1.1-.Th, aGC CD1d tet CD3e, Thymus, avg-2 | 3.88e-04 | 398 | 94 | 8 | GSM538338_500 | |
| CoexpressionAtlas | B cells, proB.FrBC.FL, CD19+ IgM- CD43+ CD24+ AA4.1+ CD45R+, Fetal Liver, avg-3 | 4.01e-04 | 400 | 94 | 8 | GSM538358_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | SLK NWD1 AFF2 ECPAS TRIM24 CDC14B BLM TET1 CKAP2L TTI1 MACF1 SKA1 ZNF292 | 4.08e-04 | 989 | 94 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#3_top-relative-expression-ranked_200 | 4.16e-04 | 33 | 94 | 3 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k3_200 | |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | 4.65e-04 | 409 | 94 | 8 | GSM399452_500 | |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | 5.28e-04 | 417 | 94 | 8 | GSM399403_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.83e-04 | 323 | 94 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k5 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.PP, TCR+ CD4+ CD44low CD62Lhigh, Peyer's Patch, avg-2 | 6.27e-04 | 327 | 94 | 7 | GSM538380_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | DDX59 MYO9A COG6 PCDH19 TET1 CKAP2L TTI1 MACF1 SLC2A13 ZMYM4 PLXNA2 | 6.60e-04 | 780 | 94 | 11 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.43e-12 | 174 | 97 | 10 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.19e-12 | 179 | 97 | 10 | 4166c4e1a8748a79ac6a11fd0b97c5344be2321b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-11 | 187 | 97 | 10 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.77e-11 | 196 | 97 | 10 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 2.89e-10 | 185 | 97 | 9 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-10 | 185 | 97 | 9 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.50e-10 | 189 | 97 | 9 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.41e-10 | 194 | 97 | 9 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.61e-10 | 195 | 97 | 9 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.83e-10 | 196 | 97 | 9 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.83e-10 | 196 | 97 | 9 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.83e-10 | 196 | 97 | 9 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.05e-10 | 197 | 97 | 9 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.05e-10 | 197 | 97 | 9 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_ventral_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 5.52e-10 | 199 | 97 | 9 | 446cd7d960812519fe2b8e434578ef0b668c75ce | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells-Neuroepithelial_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 5.77e-10 | 200 | 97 | 9 | c88d8e67647c90d1fa2569516865a9fd766eaf1c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 5.77e-10 | 200 | 97 | 9 | 28935053cd6918cd2e9f3e7691f8522216585cb6 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.74e-09 | 163 | 97 | 8 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-09 | 167 | 97 | 8 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.59e-09 | 174 | 97 | 8 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.25e-09 | 177 | 97 | 8 | 8a74f5e72de605774111057bd87a7e7e4a6385cd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.73e-09 | 179 | 97 | 8 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.73e-09 | 179 | 97 | 8 | 80112c686a8f85ad5e3cda6e3f3d3d51cf688092 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-09 | 180 | 97 | 8 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.26e-09 | 181 | 97 | 8 | cf13bf7a531a2d40f8d778629cf2431b684f65f3 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.26e-09 | 181 | 97 | 8 | 74311aac2fe27dc02a9be3bc20e0c7ef1c239049 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 6.82e-09 | 183 | 97 | 8 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | Dividing_Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.74e-09 | 186 | 97 | 8 | 0067eb78d4c7e32b9563550d9fcaf13445ee6a48 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.15e-09 | 190 | 97 | 8 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.15e-09 | 190 | 97 | 8 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.53e-09 | 191 | 97 | 8 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.53e-09 | 191 | 97 | 8 | 239300ff76f2c855b2b04d3002461158be90a01b | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.53e-09 | 191 | 97 | 8 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-08 | 193 | 97 | 8 | f20b90e3f3f5c9a1ae51c5ebe6d3adb954a142f2 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.03e-08 | 193 | 97 | 8 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | P03-Endothelial-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.08e-08 | 194 | 97 | 8 | 22bcfb0f3f73608feb22c0847ab4d34f87aeede0 | |
| ToppCell | P03-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.08e-08 | 194 | 97 | 8 | 5e56ce9b9fe0721be3a9e6efe1422599bb867721 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.08e-08 | 194 | 97 | 8 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-08 | 194 | 97 | 8 | 3a49c7c86036e09a8cd0114988380d04ad1a26fb | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-08 | 195 | 97 | 8 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.12e-08 | 195 | 97 | 8 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.12e-08 | 195 | 97 | 8 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-08 | 195 | 97 | 8 | 75759fd7f925725f0ecd07214afcca5aa2158f9e | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-08 | 195 | 97 | 8 | 5790b47b0e028e49b99bda8d6d9e80ac79208cdf | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.17e-08 | 196 | 97 | 8 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-08 | 197 | 97 | 8 | 954d4deaeba50c5b3faf52105c4cde961a682be1 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-08 | 197 | 97 | 8 | 2a89a724e8c15a5bb167fdad7eed31444d8c3d68 | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.26e-08 | 198 | 97 | 8 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.26e-08 | 198 | 97 | 8 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.26e-08 | 198 | 97 | 8 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-08 | 199 | 97 | 8 | 13ff6c26ebcc663ef8e5559ab9be99dab848abe7 | |
| ToppCell | proximal-Epithelial-Proliferating_Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.31e-08 | 199 | 97 | 8 | 521ff4ae3437c8ba477a0a42b9da195af976c3ff | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 1.31e-08 | 199 | 97 | 8 | 2e9ee10a069afca5dbd9f0863cf90a66db1a6ffb | |
| ToppCell | proximal-Epithelial-Proliferating_Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.31e-08 | 199 | 97 | 8 | e8549b2c4152cb23548351d9cee27c3805892cd8 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|COVID-19 / Condition, Lineage and Cell class | 1.31e-08 | 199 | 97 | 8 | e1dfc856a85a91e8f7ab8d600a8a891d16b2aefb | |
| ToppCell | proximal-3-Epithelial-Proliferating_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.31e-08 | 199 | 97 | 8 | 2263bb73d9c5693b44d91d2548305efc1b6e4079 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.36e-08 | 200 | 97 | 8 | 8f8b8c225cdc79baf16fe04be89bdb65e404a055 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.36e-08 | 200 | 97 | 8 | a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.36e-08 | 200 | 97 | 8 | 535f6fba8d03873ba35c9949579161dc41cd7a60 | |
| ToppCell | Severe_COVID-19-T/NK-proliferating_T/NK|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.36e-08 | 200 | 97 | 8 | 52265e761a961f3724b388285e0919bd58847138 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Stem_cells-Neuroepithelial_cell|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.36e-08 | 200 | 97 | 8 | c865efaaaecccbf9c833d6c1cbe85809a3ec306d | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-08 | 200 | 97 | 8 | 3c3ac587ad98e3f6be809eac18c7742a23140de1 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating-cycling_ventral_progenitors|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.36e-08 | 200 | 97 | 8 | 9359faa749f41aaef70b4874f20b4eed2dc12cc2 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Stem_cells|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.36e-08 | 200 | 97 | 8 | 2ee167b8bddd11fd5b1f61f87fcdf757aee3193e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells-Neuroepithelial_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.36e-08 | 200 | 97 | 8 | 203b9a5de4430713da01b3331e69381db449a3a0 | |
| ToppCell | PSB-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.36e-08 | 200 | 97 | 8 | 3e3de496508efb2f95e5e8684f97687381e96493 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-08 | 200 | 97 | 8 | 5c84aaedac9f27da0da0493dab7c8f7a4d66888c | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.36e-08 | 200 | 97 | 8 | 60d11275f06490f86f400a2802492f9c1b570400 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.36e-08 | 200 | 97 | 8 | a854e19703dc920e48304541e2b06ed013292f3e | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.36e-08 | 200 | 97 | 8 | 9c03a8da12d29618f72c429836c1d1bd84a78b12 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.36e-08 | 200 | 97 | 8 | cea58274efbe7f9e3c3ef9fbb768ebfb917e21d9 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.36e-08 | 200 | 97 | 8 | 7f5cd05bb1b9a83baceddb7d7f0a9ec9781cda29 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-08 | 200 | 97 | 8 | dd7ad295ab3ba4c19babffb1625900db414bb5a9 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-08 | 200 | 97 | 8 | 5e1b38e2aa8901bfb2623249f7b6302e97d56ace | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.36e-08 | 200 | 97 | 8 | 0e44a55d65b72eb40543d3bde301f8598ac251c3 | |
| ToppCell | distal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.36e-08 | 200 | 97 | 8 | 1b65c97e8123d0572d31525d6a10bc7f16857959 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.46e-08 | 161 | 97 | 7 | 0dd1401b4c990d49fccb702a9f9867590a58e203 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.46e-08 | 161 | 97 | 7 | b6a31c033edc74f23a20aab1f18e80cc83ffee4c | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.46e-08 | 161 | 97 | 7 | efb811dda4d73107983a5f68302bdcf4f408d5b4 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.46e-08 | 161 | 97 | 7 | 28d5dbd20c9f8e0069f172d552997a044790e1a7 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.33e-08 | 164 | 97 | 7 | ad508f53009efdd1dae7abcdb5431387f3f7e7b2 | |
| ToppCell | Dividing_Macrophages-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 7.97e-08 | 166 | 97 | 7 | ea95b94ccc2ac67df741b30c27f4ae698925875f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-08 | 167 | 97 | 7 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.65e-08 | 168 | 97 | 7 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.00e-08 | 169 | 97 | 7 | a949f547b53126a208819bade74a1ac9b2a36ea7 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.00e-08 | 169 | 97 | 7 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.00e-08 | 169 | 97 | 7 | 195d5cd60d646ac6d40a3321b2f739917e7aef14 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-07 | 175 | 97 | 7 | a6913f992a1ea20b43e5adeca3ede3a6fda820ad | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.14e-07 | 175 | 97 | 7 | d43ae33a6256606ce848247cad32d74f21b38988 | |
| ToppCell | Dividing_Macrophages-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.14e-07 | 175 | 97 | 7 | 0a8bf455babb3271aa00642199fb58b0b02dc3ac | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-07 | 175 | 97 | 7 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.19e-07 | 176 | 97 | 7 | d70fdc7bc48719776ed1e7c01118385e3a21623f | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.19e-07 | 176 | 97 | 7 | a84361308e5e96f3a30246cd29e109c321ee65bf | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.19e-07 | 176 | 97 | 7 | 8385435074cc5235b7af7424974f609388fc2cff | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-07 | 179 | 97 | 7 | df4d0b2fe47d2c7def729b3217cb01ced01495ff | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-07 | 180 | 97 | 7 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-07 | 180 | 97 | 7 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.44e-07 | 181 | 97 | 7 | 0c5bc1660b8fc1e905ab4230202862de5be46ebd | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.44e-07 | 181 | 97 | 7 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.44e-07 | 181 | 97 | 7 | f83565f09dd971c5cad2704a4a86bca0accd955e | |
| Disease | Ovarian Serous Adenocarcinoma | 8.16e-07 | 23 | 94 | 4 | C1335177 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 1.99e-05 | 50 | 94 | 4 | EFO_0022247 | |
| Disease | Bloom syndrome (implicated_via_orthology) | 3.01e-05 | 3 | 94 | 2 | DOID:2717 (implicated_via_orthology) | |
| Disease | cholesterol to total lipids in IDL percentage | 4.11e-05 | 60 | 94 | 4 | EFO_0022233 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 9.37e-05 | 74 | 94 | 4 | EFO_0022280 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.67e-04 | 364 | 94 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | Alzheimer's disease 1 (implicated_via_orthology) | 2.09e-04 | 7 | 94 | 2 | DOID:0080348 (implicated_via_orthology) | |
| Disease | osteoarthritis, hip | 2.18e-04 | 92 | 94 | 4 | EFO_1000786 | |
| Disease | monocyte count | THEMIS2 AFF2 CLASP1 IQCN NSMCE2 GGT5 RASSF5 CYRIA IFRD1 LPA TLN1 FCRL5 SSH2 | 2.81e-04 | 1320 | 94 | 13 | EFO_0005091 |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 3.36e-04 | 103 | 94 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | fetuin-B measurement | 4.44e-04 | 10 | 94 | 2 | EFO_0008128 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 4.57e-04 | 307 | 94 | 6 | EFO_0004612, EFO_0020946 | |
| Disease | hippocampal CA1 volume | 4.88e-04 | 48 | 94 | 3 | EFO_0009394 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 5.51e-04 | 50 | 94 | 3 | EFO_0022303 | |
| Disease | vital capacity | PPP1R21 KNTC1 PTCH1 PKD1L3 TRIM24 CDC14B JMJD1C CCNYL1 ASTN2 RPRD2 UTRN SMAD3 | 5.56e-04 | 1236 | 94 | 12 | EFO_0004312 |
| Disease | triglycerides to total lipids in large LDL percentage | 5.84e-04 | 51 | 94 | 3 | EFO_0022331 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 5.84e-04 | 51 | 94 | 3 | EFO_0022302 | |
| Disease | cognitive function measurement | KNTC1 SYNPO2 THSD7A CLASP1 PTCH1 PKD1L3 CDC14B JMJD1C MYO3A CYRIA PLAA RNF10 GABPA | 6.15e-04 | 1434 | 94 | 13 | EFO_0008354 |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 6.17e-04 | 121 | 94 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | smoking behavior, BMI-adjusted waist circumference | 6.37e-04 | 122 | 94 | 4 | EFO_0004318, EFO_0007789 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 6.53e-04 | 53 | 94 | 3 | EFO_0022340 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 6.53e-04 | 53 | 94 | 3 | EFO_0022286 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 6.53e-04 | 53 | 94 | 3 | EFO_0022258 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 6.90e-04 | 54 | 94 | 3 | EFO_0022244 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 7.40e-04 | 127 | 94 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | triglycerides in large VLDL measurement | 7.68e-04 | 56 | 94 | 3 | EFO_0022178 | |
| Disease | triglycerides in very large VLDL measurement | 7.68e-04 | 56 | 94 | 3 | EFO_0022325 | |
| Disease | triglycerides in chylomicrons and extremely large VLDL measurement | 7.68e-04 | 56 | 94 | 3 | EFO_0022316 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 7.68e-04 | 56 | 94 | 3 | EFO_0022250 | |
| Disease | myeloid white cell count | THEMIS2 NSMCE2 JMJD1C GGT5 RASSF5 CYRIA TLN2 FCRL5 SSH2 ZNF292 | 8.08e-04 | 937 | 94 | 10 | EFO_0007988 |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 8.09e-04 | 57 | 94 | 3 | EFO_0022284 | |
| Disease | phospholipids:total lipids ratio | 8.12e-04 | 227 | 94 | 5 | EFO_0020946 | |
| Disease | cystic fibrosis associated meconium ileus | 8.91e-04 | 14 | 94 | 2 | EFO_0004608 | |
| Disease | triglycerides in VLDL measurement | 8.94e-04 | 59 | 94 | 3 | EFO_0022326 | |
| Disease | triglycerides to total lipids in small LDL percentage | 8.94e-04 | 59 | 94 | 3 | EFO_0022337 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 8.94e-04 | 59 | 94 | 3 | EFO_0022260 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 9.39e-04 | 60 | 94 | 3 | EFO_0021898 | |
| Disease | total lipids in VLDL measurement | 9.39e-04 | 60 | 94 | 3 | EFO_0022314 | |
| Disease | body fat percentage | 9.62e-04 | 488 | 94 | 7 | EFO_0007800 | |
| Disease | triglycerides in small VLDL measurement | 9.86e-04 | 61 | 94 | 3 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 9.86e-04 | 61 | 94 | 3 | EFO_0022274 | |
| Disease | triglycerides in small HDL measurement | 1.03e-03 | 62 | 94 | 3 | EFO_0022158 | |
| Disease | phospholipids in large VLDL measurement | 1.03e-03 | 62 | 94 | 3 | EFO_0022169 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 1.03e-03 | 62 | 94 | 3 | EFO_0022339 | |
| Disease | total lipids in chylomicrons and extremely large VLDL measurement | 1.03e-03 | 62 | 94 | 3 | EFO_0022306 | |
| Disease | total lipids in very large VLDL measurement | 1.03e-03 | 62 | 94 | 3 | EFO_0022313 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 1.03e-03 | 62 | 94 | 3 | EFO_0022263 | |
| Disease | phospholipids in very large VLDL measurement | 1.03e-03 | 62 | 94 | 3 | EFO_0022299 | |
| Disease | triglycerides to total lipids in IDL percentage | 1.08e-03 | 63 | 94 | 3 | EFO_0022329 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 1.08e-03 | 63 | 94 | 3 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 1.08e-03 | 63 | 94 | 3 | EFO_0022239 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 1.08e-03 | 63 | 94 | 3 | EFO_0022283 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 1.08e-03 | 63 | 94 | 3 | EFO_0022292 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.10e-03 | 243 | 94 | 5 | EFO_0004612, EFO_0020944 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 1.13e-03 | 64 | 94 | 3 | EFO_0022253 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.18e-03 | 144 | 94 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | cholesterol in large VLDL measurement | 1.19e-03 | 65 | 94 | 3 | EFO_0021902 | |
| Disease | endometriosis | 1.29e-03 | 252 | 94 | 5 | EFO_0001065 | |
| Disease | total lipids in large VLDL | 1.29e-03 | 67 | 94 | 3 | EFO_0022175 | |
| Disease | spinal stenosis | 1.32e-03 | 17 | 94 | 2 | EFO_0007490 | |
| Disease | triglycerides to phosphoglycerides ratio | 1.35e-03 | 68 | 94 | 3 | EFO_0022327 | |
| Disease | free cholesterol in large VLDL measurement | 1.35e-03 | 68 | 94 | 3 | EFO_0022265 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 1.37e-03 | 150 | 94 | 4 | EFO_0004611, EFO_0020947 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 1.41e-03 | 69 | 94 | 3 | EFO_0022341 | |
| Disease | apolipoprotein A 1 measurement | 1.54e-03 | 848 | 94 | 9 | EFO_0004614 | |
| Disease | electrocardiography | 1.55e-03 | 530 | 94 | 7 | EFO_0004327 | |
| Disease | triglycerides to total lipids in small HDL percentage | 1.59e-03 | 72 | 94 | 3 | EFO_0022336 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 1.79e-03 | 75 | 94 | 3 | EFO_0022287 | |
| Disease | Osteoarthritis of hip | 1.84e-03 | 20 | 94 | 2 | C0029410 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.92e-03 | 276 | 94 | 5 | EFO_0004612, EFO_0020943 | |
| Disease | reticulocyte measurement | CLASP1 COBLL1 ECPAS SGO1 JMJD1C RASSF5 CDH20 TLN2 ARMH4 MYBL2 | 1.93e-03 | 1053 | 94 | 10 | EFO_0010700 |
| Disease | alcohol consumption measurement | WAPL THSD7A COBLL1 PKD1L3 SEZ6L2 CYRIA ASTN2 RPRD2 SLC2A13 PLXNA2 ARMH4 | 1.99e-03 | 1242 | 94 | 11 | EFO_0007878 |
| Disease | red blood cell density measurement | 1.99e-03 | 880 | 94 | 9 | EFO_0007978 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 2.00e-03 | 78 | 94 | 3 | EFO_0022187 | |
| Disease | docosahexaenoic acid to total fatty acids percentage | 2.03e-03 | 21 | 94 | 2 | EFO_0022262 | |
| Disease | neuroimaging measurement | 2.16e-03 | 1069 | 94 | 10 | EFO_0004346 | |
| Disease | age at voice drop | 2.23e-03 | 22 | 94 | 2 | EFO_0007888 | |
| Disease | migraine disorder, Headache | 2.65e-03 | 86 | 94 | 3 | HP_0002315, MONDO_0005277 | |
| Disease | sexual dimorphism measurement | COBLL1 PTCH1 PKD1L3 SEZ6L2 JMJD1C GPIHBP1 LPA MACF1 PAPPA SMAD3 | 2.75e-03 | 1106 | 94 | 10 | EFO_0021796 |
| Disease | platelet component distribution width | 2.85e-03 | 755 | 94 | 8 | EFO_0007984 | |
| Disease | Cardiac Arrhythmia | 2.87e-03 | 25 | 94 | 2 | C0003811 | |
| Disease | brain volume measurement | 2.95e-03 | 595 | 94 | 7 | EFO_0006930 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KATATTSQPVLTIQQ | 121 | Q12979 | |
| VVNSAVSDCPTLKTK | 171 | Q6P461 | |
| PLELCLTSNVKSQTV | 256 | Q6DHV7 | |
| PLTVILQSSVQSCKT | 446 | O60729 | |
| LQSSVQSCKTSEPNI | 451 | O60729 | |
| SIVENTCIITPTAKA | 331 | Q8NEB7 | |
| LEPVKTLTTQCTATE | 436 | P51816 | |
| ENSSVTSKQTPQLVV | 56 | Q86TY3 | |
| TIISDPTCEITQNTV | 426 | Q14956 | |
| KVVISLCQSQNLPSS | 236 | Q569K6 | |
| STVSQPNLRTTVKCV | 131 | Q8N7R7 | |
| VTIPASQVSTQNLKT | 956 | Q53SF7 | |
| TCISKSFTTRNQVEP | 556 | O95905 | |
| PVNKTALTLIAVSSC | 431 | O75129 | |
| TKCESSTQTNTHILP | 511 | Q8IYR0 | |
| DVKTPNTETRTSCLI | 576 | Q8WWK9 | |
| SSIKEETPTCAVSVQ | 1041 | Q149M9 | |
| SVKELPTVTTNVQNS | 106 | Q96B01 | |
| TKCLENTKVTQTPES | 61 | P61576 | |
| ITTICLKSIQVGSQP | 256 | Q6ZSC3 | |
| TLTVTFSQNVCKPVE | 186 | Q8WWW0 | |
| KTQSRGQPITDITTC | 741 | Q9H0B3 | |
| CKVSSPTVNTTLRNL | 456 | Q9NSK0 | |
| KRTVDVTICSPKVNS | 1036 | Q8TAB3 | |
| NKTLPIENTTDCLST | 211 | Q9H0Q0 | |
| QTTETTSCLLQNVSP | 251 | Q8NFM7 | |
| IIGIPTCVKTSQTAV | 251 | Q4G0Z9 | |
| TDSCQPITKTVEGTQ | 111 | Q8IV16 | |
| VVSKVSVVNPTAQCT | 231 | O75487 | |
| VQSATPTTIKVINSS | 276 | Q06546 | |
| SVLISTTQPVVSPKC | 1721 | Q5HYC2 | |
| QECKVSTTAPVTLAS | 1446 | Q15652 | |
| SEIIKPCSVNLIAST | 1576 | Q15652 | |
| NDCQTILVSATIPTS | 376 | Q5T1V6 | |
| SVIVSLTTQCPQDLT | 1381 | Q5VYK3 | |
| VCKVVNTTTLTCLAP | 1086 | O75051 | |
| ESCCPVSSNTVKIQV | 171 | Q96RD9 | |
| EMVTCPTSISIQTTL | 2811 | Q02505 | |
| STCEQPKNTEVLRTT | 771 | Q32MH5 | |
| TQSQTNFTCPITKEE | 161 | Q96MF7 | |
| TQTIESCLLSIVNPE | 1671 | P50748 | |
| LIKSQTGPSVTVTCT | 1256 | Q13219 | |
| PTATQKLITTNDCIL | 456 | Q6ZMI0 | |
| STCEVIKSPQTNGTT | 166 | Q13491 | |
| TCEKLNLQTSTSIPN | 91 | P17301 | |
| PRTQTLCSVKDAVTV | 2381 | Q9UPN3 | |
| SLTVCSAVKTEKTPQ | 3311 | Q9UPN3 | |
| TLTQESCDVSPVLTQ | 236 | Q9Y2V7 | |
| PRKKTQTCDTSVQIE | 1101 | B1AJZ9 | |
| FLQTPKEVVCTTQNT | 111 | P54132 | |
| QPVLSSTGTLTIQVC | 581 | Q9HBT6 | |
| TIAALVCTSVVNPQS | 71 | P36269 | |
| NLTQCPVTESSVLAT | 1241 | P08519 | |
| EKDTTVICSTPNTVL | 226 | O00458 | |
| STKFSVATQTCQITP | 116 | P01042 | |
| CVNTKAVKPSISETV | 1366 | Q8NDH2 | |
| VTICQSSEVSKPKLE | 646 | Q5VT52 | |
| CKVDSPTVTTTLKNL | 456 | Q07866 | |
| LSFVDVCNSTTITPK | 66 | O95221 | |
| PSQTTVLVVICGSVK | 86 | Q9UKK6 | |
| TLCQEQTSSQPVIAK | 971 | Q9Y6R4 | |
| TVIDSSCVPVNKAST | 461 | Q96QE2 | |
| KCRILNEKVNTPTTT | 236 | P26639 | |
| TVKICTVPNSSSQLI | 156 | Q92750 | |
| TLKECIQEPSSVSQT | 2181 | P46939 | |
| PLTESQIQVVCKQTL | 126 | Q9H2G2 | |
| SLQTVNISVISKPQC | 151 | Q8IYP2 | |
| PQVTVTQSCVKGSDL | 96 | Q96BD8 | |
| SNSTLEQCTLIPVVV | 1546 | Q9UPZ6 | |
| PSLTSTPVCSQKVVV | 471 | P10244 | |
| VDCSVTQSNKVSVTP | 496 | Q05209 | |
| QTPSLVSVITAVTQC | 621 | Q7Z443 | |
| SVQPVTVTQDTLSCQ | 686 | Q13635 | |
| AAPCQIITNTSTLLK | 41 | Q5FBB7 | |
| NPVELCKTQKQSTTT | 1036 | Q562F6 | |
| TTVTTTVTSPVLCNN | 161 | Q6UXD5 | |
| ESTPTSLVTCNVQQK | 1101 | Q8NFU7 | |
| KSSQVCIPQTSCVLQ | 356 | Q8IYA6 | |
| IPVITSNCTSKSVAV | 446 | Q7Z460 | |
| TKTGIIPETQIVTCN | 121 | O15205 | |
| VPSSTVEKSNQVCTS | 151 | O15164 | |
| TTLQIRPATKTQCTE | 116 | Q9UMS6 | |
| EVLCSQSNKPVTLTV | 101 | Q92544 | |
| QLTTTECIVQSKPVE | 1326 | Q76I76 | |
| TTQNVNTKCITIPRS | 56 | P84022 | |
| LSTSQLVACTKVVAP | 711 | Q9Y490 | |
| TICTESSQQEPITKS | 481 | Q8N5U6 | |
| VTQASCAISPSQTLI | 611 | Q9NS62 | |
| LVSATTQSSKQLPTC | 96 | Q5TEJ8 | |
| SLICNSSSEKPTVQQ | 581 | Q9Y263 | |
| PASQCVLINTSVTLT | 1856 | O60281 | |
| PRVLCIIQDTTNSKT | 41 | Q96K76 | |
| KSTQPLNTRCLSVIS | 666 | Q7Z5K2 | |
| TLCDKVTQSSPDQTV | 16 | A0JD37 | |
| TSQLVACAKVVSPTI | 716 | Q9Y4G6 | |
| SLEQQSEITPKQITC | 191 | Q70CQ3 | |
| VVSVIVKNTVCPEQS | 81 | Q8N1G0 | |
| KTSCGNITRTVTQVP | 336 | Q8N1G0 | |
| QLSTTVECVPVTRSN | 491 | Q5JPB2 | |
| QCDITKTEPTTVTSA | 276 | A8MV65 | |
| TVLSSQTCEQTPERL | 601 | P01266 | |
| STEISTCSEVFQKPI | 21 | P0DJG4 | |
| PIVTINTNSISTKCS | 431 | Q5VZL5 | |
| PVCVQLTKTQTVENV | 16 | O43156 | |
| KTSVVTQRAPICSQE | 1306 | Q8NEV4 | |
| PLQSVQDISKTTTCV | 2226 | B2RTY4 |